Literature DB >> 2181303

The major surface glycoprotein (GP63) is present in both life stages of Leishmania.

T O Frommel1, L L Button, Y Fujikura, W R McMaster.   

Abstract

Leishmania exist as extracellular promastigotes which multiply in the gut of the sandfly insect vector and as intracellular amastigotes which divide in the phagolysosome of mononuclear phagocytic cells of the mammalian host. Promastigotes express a major surface glycoprotein of 63 kDa, referred to as GP63. The expression of GP63 in both Leishmania life stages was studied using rabbit antibodies against native GP63 as well as rabbit antibodies against recombinant GP63 that was synthesized in an Escherichia coli expression system. Immunofluorescence staining detected GP63 in intracellular amastigotes contained within a macrophage cell line and within freshly isolated lesion amastigotes. Western blot analysis using anti-recombinant GP63 antibodies also demonstrated that amastigotes synthesize GP63 which may undergo differential post-translational processing as compared to promastigote GP63.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181303     DOI: 10.1016/0166-6851(90)90201-v

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  12 in total

1.  Leishmania mexicana mutants lacking glycosylphosphatidylinositol (GPI):protein transamidase provide insights into the biosynthesis and functions of GPI-anchored proteins.

Authors:  J D Hilley; J L Zawadzki; M J McConville; G H Coombs; J C Mottram
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

2.  Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8.

Authors:  M Colmenares; M Tiemeyer; P Kima; D McMahon-Pratt
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

3.  Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes.

Authors:  M B Seay; P L Heard; G Chaudhuri
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Cysteine proteinases from promastigotes of Leishmania (Viannia) braziliensis.

Authors:  Karina M Rebello; Luzia M C Côrtes; Bernardo A S Pereira; Bernardo M O Pascarelli; Suzana Côrte-Real; Léa C Finkelstein; Rosa T Pinho; Claudia M d'Avila-Levy; Carlos R Alves
Journal:  Parasitol Res       Date:  2009-09-24       Impact factor: 2.289

5.  Antigenicity and conformational analysis of the Zn(2+)-binding sites of two Zn(2+)-metalloproteases: Leishmania gp63 and mammalian endopeptidase-24.11.

Authors:  K P Soteriadou; A K Tzinia; E Panou-Pamonis; V Tsikaris; M Sakarellos-Daitsiotis; C Sakarellos; Y Papapoulou; R Matsas
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

6.  Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.

Authors:  N D Connell; E Medina-Acosta; W R McMaster; B R Bloom; D G Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

7.  Extracellular release of the surface metalloprotease, gp63, from Leishmania and insect trypanosomatids.

Authors:  Charles L Jaffe; Dennis M Dwyer
Journal:  Parasitol Res       Date:  2003-08-16       Impact factor: 2.289

8.  Cell-mediated responses of immunized vervet monkeys to defined Leishmania T-cell epitopes.

Authors:  A J Curry; A Jardim; J O Olobo; R W Olafson
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Developmental changes in the expression of Leishmania chagasi gp63 and heat shock protein in a human macrophage cell line.

Authors:  J A Streit; J E Donelson; M W Agey; M E Wilson
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

Review 10.  Impact of Leishmania metalloprotease GP63 on macrophage signaling.

Authors:  Amandine Isnard; Marina T Shio; Martin Olivier
Journal:  Front Cell Infect Microbiol       Date:  2012-05-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.